Pamela Esposito - 04 Aug 2021 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role: Chief Business Officer
Signature: /s/ Jean Franchi, attorney-in-fact
Issuer symbol: REPL
Transactions as of: 04 Aug 2021
Net transactions value: -$587,322
Form type: 4
Filing time: 06 Aug 2021, 21:01:02 UTC
Previous filing: 22 Jul 2021
Next filing: 05 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REPL	Common Stock	Options Exercise	$65,100	+4,200	+2%	$15.50	214,359	04 Aug 2021	Direct
transaction	REPL	Common Stock	Sale	$147,000	-4,200	-2%	$35.00	210,159	04 Aug 2021	Direct	F1, F2
transaction	REPL	Common Stock	Options Exercise	$399,900	+25,800	+12%	$15.50	235,959	05 Aug 2021	Direct
transaction	REPL	Common Stock	Sale	$905,322	-25,800	-11%	$35.09	210,159	05 Aug 2021	Direct	F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REPL	Employee Stock Option (right to buy)	Options Exercise	$0	-4,200	-5.5%	$0.000000	71,550	04 Aug 2021	Common Stock	4,200	$15.50	Direct	F5
transaction	REPL	Employee Stock Option (right to buy)	Options Exercise	$0	-25,800	-36%	$0.000000	45,750	05 Aug 2021	Common Stock	25,800	$15.50	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2	The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.05. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3	The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.38. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4	Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 458,102 shares of the Issuer's common stock, 300,811 of which are exercisable as of the date hereof.
F5	25% of the shares underlying this stock option vested on April 1, 2020, and the remainder of the shares underlying this stock option vested or will vest, as applicable, in 36 approximately equal monthly installments thereafter.